Yin C - Search Results

1

Digitalized Adaptation of Oncology Trials during and after COVID-19.

Li G, Yin C, Zhou Y, Wang T, Chen J, Liu Y, Chen T, Wang H, Zhang L, Chen X. Li G, et al. Among authors: yin c. Cancer Cell. 2020 Aug 10;38(2):148-149. doi: 10.1016/j.ccell.2020.06.018. Epub 2020 Jul 6. Cancer Cell. 2020. PMID: 32634378 Free PMC article. No abstract available.

2

Serologic response and safety of COVID-19 vaccination in HSCT or CAR T-cell recipients: a systematic review and meta-analysis.

Ge C, Du K, Luo M, Shen K, Zhou Y, Guo K, Liu Y, Yin C, Li Y, Li G, Chen X. Ge C, et al. Among authors: yin c. Exp Hematol Oncol. 2022 Aug 16;11(1):46. doi: 10.1186/s40164-022-00299-6. Exp Hematol Oncol. 2022. PMID: 35974381 Free PMC article.

3

Gene and cell therapies in China: booming landscape under dual-track regulation.

Yin C, Gao J, Li G, Hu H, Zhou L, Lu S, Chen X. Yin C, et al. J Hematol Oncol. 2022 Oct 5;15(1):139. doi: 10.1186/s13045-022-01354-9. J Hematol Oncol. 2022. PMID: 36199142 Free PMC article.

4

Trends and Characteristics of New Drug Approvals in China, 2011-2021.

Su L, Liu S, Li G, Xie C, Yang H, Liu Y, Yin C, Chen X. Su L, et al. Among authors: yin c. Ther Innov Regul Sci. 2023 Mar;57(2):343-351. doi: 10.1007/s43441-022-00472-3. Epub 2022 Nov 2. Ther Innov Regul Sci. 2023. PMID: 36322325 Free PMC article.

5

Evolution of drug regulations and regulatory innovation for anticancer drugs in China.

Liu Y, Zhang N, Xie C, Jiang Y, Qin Y, Zhou L, Fan Y, Ren L, Yin C, Yang H, Xie W, Zhai Q, Li G, Chen H, Chen X. Liu Y, et al. Among authors: yin c. Acta Pharm Sin B. 2022 Dec;12(12):4365-4377. doi: 10.1016/j.apsb.2022.08.004. Epub 2022 Aug 13. Acta Pharm Sin B. 2022. PMID: 36561995 Free PMC article. Review.

6

Analysis of patient-reported outcomes in the approval of novel oncology drugs in the United States, 2017-2022.

Ge C, Guo K, Li Y, Li G, Zhang H, Yang J, Liu Y, Yin C, Liu S, Xie S, Chen X. Ge C, et al. Among authors: yin c. EClinicalMedicine. 2023 Apr 6;59:101953. doi: 10.1016/j.eclinm.2023.101953. eCollection 2023 May. EClinicalMedicine. 2023. PMID: 37089618 Free PMC article. Review.

7

Single-arm trials for domestic oncology drug approvals in China.

Zhang H, Liu S, Ge C, Liu X, Liu Y, Yin C, Li Y, An J, Yan Z, Chen X. Zhang H, et al. Among authors: yin c. Cancer Biol Med. 2023 Nov 27;20(11):799-805. doi: 10.20892/j.issn.2095-3941.2023.0360. Cancer Biol Med. 2023. PMID: 38013490 Free PMC article. No abstract available.

8

Rethinking Human-AI Collaboration in Complex Medical Decision Making: A Case Study in Sepsis Diagnosis.

Zhang S, Yu J, Xu X, Yin C, Lu Y, Yao B, Tory M, Padilla LM, Caterino J, Zhang P, Wang D. Zhang S, et al. Among authors: yin c. Proc SIGCHI Conf Hum Factor Comput Syst. 2024 May;2024:445. doi: 10.1145/3613904.3642343. Epub 2024 May 11. Proc SIGCHI Conf Hum Factor Comput Syst. 2024. PMID: 38835626 Free PMC article.

9

Synergistic effects of Co-pyrolysis on the immobilization and transformation of lead (Pb), chromium (Cr), nickel (Ni), and fluorine (F) in phosphogypsum-biomass mixtures.

He M, Xu R, Qu G, Fu X, Liu X, Wang H, Tian Y, Yin C. He M, et al. Among authors: yin c. J Environ Manage. 2024 Jun 1;362:121340. doi: 10.1016/j.jenvman.2024.121340. Online ahead of print. J Environ Manage. 2024. PMID: 38824889

10

Enabling the design of surgical instruments for under-resourced patients through metal additive manufacturing: ulnar shortening osteotomy as an example.

Chen KL, Yin CY, Huang HK, Huang YC, Wang JP. Chen KL, et al. Among authors: yin cy. 3D Print Med. 2024 May 31;10(1):18. doi: 10.1186/s41205-024-00220-3. 3D Print Med. 2024. PMID: 38819766 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,929 results

Search Page